PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PT. SOHO Industri Pharmasi - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12342
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PT. SOHO Industri Pharmasi (PT SOHO), a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company’s products include analgesic, anti-inflammatory, antipyretic, antibiotics, antifungal, antihistamine and antiallergy, antihyperlipidaemic, antipsychotic, antiviral, corticosteroid, h2 blocker, proton pump inhibitor, hepatoprotector, immunomodulator, musculoskeletal and osteoporosis, neurotropic and neurotonic, oral antidiabetic, sweetener, and vitamins. It products are used in the therapeutic areas of allergy and asthma, arthritis and bone infection, childrens’s growth, dermatitis, constipation, diabetes mellitus, ear, nose and throat infection, hyperacidity and immune system, among others. The company manufactures products in the forms of tablets, sugar coated, film-coated, capsules, syrup, caplets, injection, cream, gels, solution and suppositories of GMP. PT SOHO is headquartered in Jakarta, Indonesia.

PT. SOHO Industri Pharmasi – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Cumberland Pharma Enters Into Licensing Agreement With SOHO Industri Pharmasi For Caldolor 10
Equity Offering 11
Gamma Vaccines Raises Additional Funds in Private Placement 11
Gamma Vaccines Raises Additional Funds in Private Placement 12
Gamma Vaccines Raises Funds in Private Placement of Shares 13
Acquisition 14
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 14
PT. SOHO Industri Pharmasi – Key Competitors 15
PT. SOHO Industri Pharmasi – Key Employees 16
PT. SOHO Industri Pharmasi – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Key Facts 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Deals By Therapy Area, 2012 to YTD 2018 8
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cumberland Pharma Enters Into Licensing Agreement With SOHO Industri Pharmasi For Caldolor 10
Gamma Vaccines Raises Additional Funds in Private Placement 11
Gamma Vaccines Raises Additional Funds in Private Placement 12
Gamma Vaccines Raises Funds in Private Placement of Shares 13
Fresenius Kabi Acquires 51% Stake in Ethica Industri Farmasi From Soho Global Halthcare 14
PT. SOHO Industri Pharmasi, Key Competitors 15
PT. SOHO Industri Pharmasi, Key Employees 16

List of Figures
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PT. SOHO Industri Pharmasi, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PT. SOHO Industri Pharmasi:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mobidiag Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestin …
  • Krka, d. d., Novo mesto:企業の戦略・SWOT・財務情報
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Industrial Alliance Insurance and Financial Services Inc.:企業の戦略・SWOT・財務情報
    Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Industrial Alliance Insurance and Financial Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the co …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ManTech International Corporation (MANT):企業の財務・戦略的SWOT分析
    ManTech International Corporation (MANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:企業の戦略・SWOT・財務情報
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Holly Energy Partners LP:企業のM&A・事業提携・投資動向
    Holly Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Holly Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Natus Medical Incorporated (BABY)-医療機器分野:企業M&A・提携分析
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. Its offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus also offers products for diagnostic hearing assessment in …
  • Chicago Bridge & Iron Company NV (CBI):電力:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • Royal FrieslandCampina N.V.:企業の戦略・SWOT・財務情報
    Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal FrieslandCampina N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Yoshinoya Holdings Co Ltd
    Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Taneja Aerospace & Aviation Ltd.
    Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taneja Aerospace & Aviation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務分析
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆